Quality Solutions That Reduce Compliance Risks in Clinical Trials

Choose from specialized solutions that help you increase quality and efficiency. 

Get in Touch
Person on computer running quality assurance check

Why QA Teams Love TransPerfect

Our knowledge and experience in Quality Management is evidenced by our ability to create and curate strategic solutions to improve day-to-day operations / reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

    QMS Powered by Trial Interactive

    Our suite of eClinical solutions—part of TransPerfect’s Trial Interactive™ offering—improves visibility, reduces timelines, enhances quality, and mitigates risk. Explore our solutions for quality management, training management, audit management, vendor oversight, quality documents, and more.

    Learn More

    Training and Development

    We offer training support across any platform, in 200+ languages, and any subject matter. Our team centralizes your global learning requirements and manages the administrative work, so you can roll out your content quickly and cost-effectively.

    Learn More

    Language/Translation Solutions

    Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

    Learn More

    Your Partner in Risk Mitigation

    Ensuring quality from R&D through commercialization is complex due to ever-evolving regulations, international policy, and corporate change, among many other variables. QA teams need all the support they can get to embed quality in the organizational culture through efficiencies such as digital and automated work streams, real-time oversight, e-learning, and translated quality documentation for multilingual operations.

    Improved Outcomes by the Numbers

    85% of clinical trials experience delays. Mitigating compliance risks by streamlining QA operations is a key strategy for preventing costly delays caused by CAPAs and inspection findings.

    1.2 M

    Saved by CRAs using our CTMS for day-to-day operations


    7.5 k

    Studies managed in Trial Interactive

    100 +

    TMFs rescued mid-study

    3 k

    eTMF study migrations completed

    50 %

    Faster site activation

    News and Thought Leadership

    Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

    The C3 Summit: Boston Recap

    The second event in our series of C3 Summits took place in Boston on May 16, 2023. We invited industry experts and leaders to discuss challenges, opportunities, and strategies in clinical trial diversity, centricity, and outcome assessments through the lens of real-world experience. In this recap of the Boston session, we will review key points from each session.  Session 1: COA/eCOA Innovations – Licensing Hiccups, Linguistic Validation, ePRO Migration, and Best ...

    The C3 Summit: Boston Recap

    How Medical Writing Can Drive Patient Engagement

    Medical writing is a critical component of the broader patient engagement landscape, establishing the foundations of communication between pharmaceutical companies and patients. The quality of medical communication can be transformational in how a patient engages with and...

    A Conversation with Dr. Elin Haf Davies of Aparito

    The rare disease space presents numerous challenges for clinical research and patient data capture. These challenges are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately. Join Dr. Elin Haf Davies, Founder & ...

    Navigating the EU Clinical Trial Regulation Complexities - Current Challenges and Opportunities

    As the most significant change in the European Union clinical trial legislative ecosystem in 20 years, the European Union Clinical Trial Regulation 536/2014 (EU CTR) went live on January 31, 2022. The first-year transition period has now ended, and from January 31, 2023, EU ...

    How to Maximise Value and Avoid Failure During Life Sciences Dealmaking

    Please complete the form below to access the on-demand recording of our webinar. A fantastic expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best practices ...

    Centralizing Global Content Solutions for Medical Affairs

    With a rapidly evolving landscape and the introduction of new technologies and emerging therapeutics, medical affairs professionals are tasked with remaining in lockstep with the latest industry developments. From a content perspective, this means not only maintaining clear...

    Automation for MDR & IVDR: A Three-Part Seminar - Part 3: EnCompass Step by Step: A Detailed View of the Content Automation Solution to Meet MDR & IVDR Requirements

    Part 3: EnCompass Step by Step: A Detailed View of the Content Automation Solution to Meet MDR & IVDR Requirements ...

    Trusted by Life Sciences Organizations Big and Small

    Gilead
    Boehringer Ingelheim
    Syneos Health
    Vertex
    Bayer
    Johnson & Johnson logo
    IQVIA
    CVS Health
    BMS
    Merck
    Biogen
    Novartis
    Pfizer logo
    Roche logo

    Working in QA? Let’s connect.